Objective:Candida is the most common cause of fungal infections. The aim of this study was to fill the gaps in the current knowledge on the frequencies of micronuclei and nuclear anomalies, and the nucleus/cytoplasmic ratio in genital candidiasis. Study Design: A total of 88 Papanicolaou- stained cervical smears, which comprised Candida spp. (n = 44) and control cases with no infectious agent (n = 44), were studied. In each smear, cells with micronuclei and nuclear anomalies were counted in 1,000 epithelial cells and also nuclear and cellular areas were evaluated using image analysis software at a magnification of ×400. Results: The frequencies of micronucleated and binucleated cells and cells with perinuclear halos, and the nucleus/cytoplasmic ratio of epithelial cells were higher in the Candida-infected group compared with the control group (p < 0.05). Conclusions: Genital candidiasis is able to induce changes in the size and shape of epithelial cells. The nuclear/cytoplasmic ratio and the frequency of micronuclei may reflect the DNA damage in the cervical epithelium. Micronucleus scoring could be used to screen the genomic damage profile of epithelial cells in candidiasis.

1.
Achkar JM, Fries BC: Candida infections of the genitourinary tract. Clin Microbiol Rev 2010;23:253-273.
2.
Fidel PL, Vazquez J, Sobel JD: Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96.
3.
Sobel JD, Myers PG, Kaye D, Levison ME: Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis 1981;143:76-82.
4.
Briones-Martin-Del-Campo MBM, Orta-Zavalva E, Juarez-Cepeda J, et al: The oxidative stress response of the opportunistic fungal pathogen Candida glabrata. Rev Iberoam Micol 2014;31:67-71.
5.
Zamora-Perez AL, Ortiz-Garcia YM, Lazalde-Ramos BP, et al: Increased micronuclei and nuclear abnormalities in buccal mucosa and oxidative damage in saliva from patients with chronic and aggressive periodontal diseases. J Periodontal Res 2015;50:28-36.
6.
Jen MH, Hwang JJ, Yang JY, Nabyvanets YB, Hsieh WA, Tsai MH, Guo SD, Chang WP: Micronuclei and nuclear anomalies in urinary exfoliated cells of subjects in radionuclide-contaminated regions. Mutat Res 2002;520:39-46.
7.
Loss R, Sandrin R, França BHS, de Azevedo-Alanis LR, Grégio AMT, Machado MAN, de Lima AS: Cytological analysis of the epithelial cells in patients with oral candidiasis. Mycoses 2011;54:130-135.
8.
Rosin MP, Anwar W: Chromosomal damage in urothelial cells from Egyptians with chronic Schistosoma haematobium infections. Int J Cancer 1992;50:539-543.
9.
Ogden GR, Wight AJ, Rice P: Effect of alcohol on the oral mucosa assessed by quantitative cytomorphometry. J Oral Pathol Med 1999;28:216-220.
10.
Wen CH, Lin CH, Tsao SC, Su YC, Tsai MH, Chai CY: Micronucleus scoring in liver fine needle aspiration cytology. Cytopathology 2013;24:391-395.
11.
Samanta S, Dey P, Nijhawan R: Micronucleus in cervical intraepithelial lesions and carcinoma. Acta Cytol 2011;55:42-47.
12.
Cortés-Gutiérrez E, Dávila-Rodríguez M, Vargas-Villarreal J, Hernández-Garza F, Cerda-Flores RM: Association between human papilloma virus-type infections with micronuclei frequencies. Prague Med Rep 2010;111:35-41.
13.
Cassel APR, Barcellos RB, da Silva CMD, Almeida SEM, Rossetti MLR: Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology. Genet Mol Biol 2014;37:360-363.
14.
Tolbert P, Shy CM, Allen JW: Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat Res 1992;271:69-77.
15.
Fenech M, Kirsch-Volders M, Natarajan, et al: Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 2011;26:125-132.
16.
Thomas P, Harvey S, Gruner T, Fenech M: The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls. Mutat Res 2008;638:37-47.
17.
Bonassi S, Coskun E, Ceppi M, et al: The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocol. Mutat Res 2011;728:88-97.
18.
Verma S, Dey P: Correlation of morphological markers of chromosomal instability in fine needle aspiration cytology with grade of breast cancer. Cytopathology 2014;25:259-263.
19.
Samanta S, Dey P: Micronucleus and its applications. Diagn Cytopathol 2012;40:84-90.
20.
Ramos MA, Cury Fde P, Scapulatempo Neto C, Marques MM, Silveira HC: Micronucleus evaluation of exfoliated buccal epithelial cells using liquid-based cytology preparation. Acta Cytol 2014;58:579-585.
21.
Sundaram A, Grant CM: Oxidant-specific regulation of protein synthesis in Candida albicans. Fungal Genet Biol 2014;67:15-23.
22.
Safi Oz Z: The interaction between human papillomavirus proteins and cytoskeletal filaments; in Vanden Broeck D (ed): Human Papillomavirus and Related Diseases - From Bench to Bedside - Research Aspects. Rijeka, InTech, 2012, pp 291-310.
23.
Bindu L, Balaram P, Mathew A, Remani P, Bhattathiri VN, Nair MK: Radiation-induced changes in oral carcinoma cells - a multiparametric evaluation. Cytopathology 2003;14:287-293.
24.
Marewicz E, Michalik M, Macura AB: Changes in actin cytoskeleton are involved in the cytopathic action of Candida albicans upon human skin fibroblasts. Folia Histochem Cytobiol 1995;33:157-162.
25.
Sandovsky-Losica H, Berdicevsky I, Tsarfaty I, Segal E: Effect of Candida albicans metabolite(s) on cellular actin. FEMS Microbiol Lett 2002;215:57-62.
26.
Segal E: Candida-mammalian cell interactions: effect on the cytoskeleton. Mycoses 2002;45(suppl 2):55.
27.
Dalle-Donne I, Rossi R, Milzani A, Di Simplicio P, Colombo R: The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself (review). Free Radic Biol Med 2001;31:1624-1632.
28.
Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A, Abad-Diaz-de-Cerio A, Hernando FL: Candida albicans and cancer: can this yeast induce cancer development or progression? Crit Rev Microbiol 2014;25:1-13.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.